This case study aims to emphasize the value of Fractional exhaled Nitric Oxide (FeNO) testing in asthma care and explain why the NObreath ® FeNO device is the product of choice. The NObreath ® ...
The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果